RAPID Pathway: Transforming Medicare Coverage for Breakthrough Devices
Discover how the RAPID pathway streamlines Medicare coverage for breakthrough devices, improving access and accelerating reimbursement processes.
Court Ruling on Medication Abortion: Implications for California Leadership
Explore how the 5th Circuit's abortion ruling affects California's healthcare leadership and insurance industry responses to regulatory changes.
Concerns Over ACA Cuts and Medicaid Eligibility Changes
Explore concerns from Congress about potential ACA funding cuts and their impact on healthcare access for millions. Understand the implications of budget allocations.
Impact of the One Big Beautiful Bill on Medicaid Spending
Examine the impact of the One Big Beautiful Bill on Medicaid spending, accessibility, and its implications for healthcare services and insurance reforms.
Atrium Health and WakeMed Merger: Transforming Regional Healthcare
The anticipated merger between WakeMed and Atrium Health aims to enhance community health and create significant economic impact in Wake County.
Nebraska Implements Work Requirements for Medicaid Recipients
Nebraska's new work requirements for Medicaid recipients signal a major policy shift. Learn how this may affect healthcare coverage and compliance challenges.
Revising Healthcare Guidelines: Impact of USPSTF Changes under Kennedy
Explore the potential impacts of the USPSTF reforms initiated by Kennedy on health insurance coverage and preventive guidelines for millions of Americans.
State Health Policy and Substance Use Disorder Treatments
Discover insights on how state policies affect Medicaid compliance for substance use disorder treatments. A crucial analysis for healthcare decision-makers.
Medicaid Policy Impact Initiative at Cornell: A New Era in Health Policy Research
Discover the Medicaid Policy Impact Initiative at Cornell, aiming to enhance health equity and inform policy decisions with robust data analysis. Join the effort!
Legal Challenge to CMS's BEI Program: Implications for FDA and Medicaid
A legal challenge against CMS's BEI program raises concerns over FDA regulation, impacting cannabinoid products in Medicare and competition for FDA-approved treatments.